When and how to use carboplatin in metastatic castration-resistant prostate cancer?

Omlin, A; Gillessen, S

Omlin, A; Gillessen, S.

Afiliação

Omlin A; Cantonal Hospital St. Gallen, Department of Oncology and Haematology, St. Gallen, Switzerland; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland. Electronic address: aurelius.omlin@kssg.ch.
Gillessen S; Cantonal Hospital St. Gallen, Department of Oncology and Haematology, St. Gallen, Switzerland; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

Eur J Cancer ; 92: 96-99, 2018 03.

Article em En | MEDLINE | ID: mdl-29395685

Assuntos

Carboplatina; Neoplasias de Próstata Resistentes à Castração; Humanos; Masculino; Taxoides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carboplatina / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google